The New News about Lithium: An Underutilized Treatment in the United States
Open Access
- 4 October 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 43 (5), 1174-1179
- https://doi.org/10.1038/npp.2017.238
Abstract
Lithium use for the treatment of mood disorders remains quite low, particularly in the United States compared with some European countries. Mogens Schou pioneered the study of lithium for prophylaxis of the recurrent mood disorder and encouraged its greater use. In an effort to further address the appropriate role of this drug, the multiple assets of lithium beyond its well-known antimanic effect are reviewed, and a brief summary of its side effects is outlined. It appears that lithium has positive effects in depression and suicide prevention, cognition, and reducing the incidence of dementia. It increases the length of telomeres and has positive effects in prevention of some medical illnesses. Lithium side-effect burden, especially its association with end-stage renal disease, may be less than many have surmised. New data indicate the importance of long-term prophylaxis after a first manic episode to lessen episode recurrence, allow cognition to recover to normal, and prevent various aspects of illness progression. After a first manic episode, 1 year of randomized treatment with lithium was superior to that of quetiapine, suggesting the importance of having lithium in the treatment regimen. Given the highly recurrent and progressive course of bipolar disorder sometimes even in the face of conventional treatment, the role and enhanced use of lithium deserves reconsideration.This publication has 59 references indexed in Scilit:
- Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeresTranslational Psychiatry, 2013
- Treatment in a specialised out-patient mood disorder clinicv.standard out-patient treatment in the early course of bipolar disorder: randomised clinical trialThe British Journal of Psychiatry, 2013
- Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar DisorderPharmacological Reviews, 2013
- A Randomized Controlled Trial of Risperidone, Lithium, or Divalproex Sodium for Initial Treatment of Bipolar I Disorder, Manic or Mixed Phase, in Children and AdolescentsArchives of General Psychiatry, 2012
- Low-dose lithium uptake promotes longevity in humans and metazoansEuropean Journal of Nutrition, 2011
- Lifetime Prevalence of Mental Disorders in U.S. Adolescents: Results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A)Journal of the American Academy of Child & Adolescent Psychiatry, 2010
- Pharmacological and non‐drug treatment of child bipolar I disorder during prospective eight‐year follow‐upBipolar Disorders, 2010
- Does lithium protect against dementia?Bipolar Disorders, 2010
- Lithium-induced Nephrogenic Diabetes InsipidusClinical Journal of the American Society of Nephrology, 2008
- Beta blockade in lithium tremor.Journal of Neurology, Neurosurgery & Psychiatry, 1975